Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging

被引:17
|
作者
Giacomucci, G. [1 ]
Monforte, M. [2 ]
Diaz-Manera, J. [3 ,4 ]
Mul, K. [5 ]
Torron, R. Fernandez [6 ,7 ]
Maggi, L. [8 ]
Bettolo, C. Marini [6 ]
Dahlqvist, J. R. [9 ]
Haberlova, J. [10 ,11 ]
Camano, P. [12 ,13 ]
Gros, M. [14 ,15 ]
Tartaglione, T. [16 ]
Cristiano, L. [16 ]
Gerevini, S. [17 ]
Calandra, P. [18 ]
Deidda, G. [18 ]
Giardina, E. [19 ]
Sacconi, S. [14 ,15 ]
Straub, V [6 ]
Vissing, J. [9 ]
Van Engelen, B. [5 ]
Ricci, E. [1 ,2 ]
Tasca, G. [2 ]
机构
[1] Univ Cattolica Sacro Cuore, Ist Neurol, Rome, Italy
[2] Fdn Policlin Univ A Gemelli IRCCS, Unita Operat Complessa Neurol, Rome, Italy
[3] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Neurol, Neuromuscular Disorders Unit, Barcelona, Spain
[4] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain
[5] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Neurol, Med Ctr, Nijmegen, Netherlands
[6] Newcastle Univ, John Walton Muscular Dystrophy Res Ctr, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England
[7] Hosp Donostia, Biodonostia Hlth Res Inst, Neurol Dept, Basque Hlth Serv,Neuromuscular Area, Donostia San Sebastian, Spain
[8] Fdn IRCCS Ist Neurol Carlo Besta, Neuroimmunol & Neuromuscular Dis Unit, Milan, Italy
[9] Copenhagen Univ Hosp, Rigshosp, Copenhagen Neuromuscular Ctr, Copenhagen, Denmark
[10] Charles Univ Prague, Fac Med 2, Dept Pediat Neurol, Prague, Czech Republic
[11] Univ Hosp Moto, Prague, Czech Republic
[12] Grp Neuromuscular Dis, Neurosci Area, Biodonostia, San Sebastian, Spain
[13] Biodonostia Osakidetza Basque Hlth Serv, Mol Diagnost Platform, San Sebastian, Spain
[14] Univ Cote Azur UCA, Muscle & ALS Dept, Pasteur Hosp 2, Peripheral Nervous Syst, Nice, France
[15] Univ Cote Azur, Inst Res Canc & Aging Nice IRCAN, CNRS, INSERM, Nice, France
[16] Ist Dermopat Immacolata IRCCS FLMM, Radiol Unit, Rome, Italy
[17] IRCCS San Raffaele Hosp, Neuroradiol Dept, Milan, Italy
[18] Natl Res Council Italy, Inst Cell Biol & Neurobiol, Rome, Italy
[19] Univ Roma Tor Vergata, Mol Genet Lab UILDM, Santa Lucia Fdn IRCSS, Rome, Italy
基金
欧盟地平线“2020”;
关键词
facioscapulohumeral muscular dystrophy; FSHD; FSHD2; muscle MRI; neuromuscular diseases; MUSCLE INVOLVEMENT; DISEASE SEVERITY; SMCHD1; MRI; MUTATIONS; GENE; D4Z4; VARIABILITY; METHYLATION; FEATURES;
D O I
10.1111/ene.14446
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose The aim was to define the radiological picture of facioscapulohumeral muscular dystrophy 2 (FSHD2) in comparison with FSHD1 and to explore correlations between imaging and clinical/molecular data. Methods Upper girdle and/or lower limb muscle magnetic resonance imaging scans of 34 molecularly confirmed FSHD2 patients from nine European neuromuscular centres were analysed. T1-weighted and short-tau inversion recovery (STIR) sequences were used to evaluate the global pattern and to assess the extent of fatty replacement and muscle oedema. Results The most frequently affected muscles were obliquus and transversus abdominis, semimembranosus, soleus and gluteus minimus in the lower limbs; trapezius, serratus anterior, latissimus dorsi and pectoralis major in the upper girdle. Iliopsoas, popliteus, obturator internus and tibialis posterior in the lower limbs and subscapularis, spinati, sternocleidomastoid and levator scapulae in the upper girdle were the most spared. Asymmetry and STIR hyperintensities were consistent features. The pattern of muscle involvement was similar to that of FSHD1, and the combined involvement of trapezius, abdominal and hamstring muscles, together with complete sparing of iliopsoas and subscapularis, was detected in 91% of patients. Peculiar differences were identified in a rostro-caudal gradient, a predominant involvement of lower limb muscles compared to the upper girdle, and in the higher percentage of STIR hyperintensities in FSHD2. Conclusion This multicentre study defines the pattern of muscle involvement in FSHD2, providing useful information for diagnostics and clinical trial design. Both similarities and differences between FSHD1 and FSHD2 were detected, which is also relevant to better understand the pathogenic mechanisms underlying the FSHD-related disease spectrum.
引用
收藏
页码:2604 / 2615
页数:12
相关论文
共 50 条
  • [41] Congenital muscular dystrophy of the Ullrich type. Utility of the magnetic muscular resonance in the diagnosis
    Llanos Carrasco-Marina, M.
    Quijano-Roy, Susana
    Iglesias-Escalera, Gemma
    Jorge-Blanco, Ana
    Carro-Martinez, Ana
    Gutierrez-Cruz, Nuria
    REVISTA DE NEUROLOGIA, 2015, 61 (01) : 44 - 46
  • [42] Five-year follow-up study on quantitative muscle magnetic resonance imaging in facioscapulohumeral muscular dystrophy: The link to clinical outcome
    Vincenten, Sanne C. C.
    Mul, Karlien
    van As, Daniel
    Jansen, Julia J.
    Heskamp, Linda
    Heerschap, Arend
    van Engelen, Baziel G. M.
    Voermans, Nicol C.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2023, 14 (04) : 1695 - 1706
  • [43] Phenotype-genotype relations in facioscapulohumeral muscular dystrophy type 1
    Mul, Karlien
    Voermans, Nicol C.
    Lemmers, Richard J. L. F.
    Jonker, Marianne A.
    van der Vliet, Patrick J.
    Padberg, George W.
    van Engelen, Baziel G. M.
    van der Maarel, Silvere M.
    Horlings, Corinne G. C.
    CLINICAL GENETICS, 2018, 94 (06) : 521 - 527
  • [44] Longitudinal 2-point dixon muscle magnetic resonance imaging in becker muscular dystrophy
    Bonati, Ulrike
    Schmid, Maurice
    Hafner, Patricia
    Haas, Tanja
    Bieri, Oliver
    Gloor, Monika
    Fischmann, Arne
    Fischer, Dirk
    MUSCLE & NERVE, 2015, 51 (06) : 918 - 921
  • [45] An epigenetic basis for genetic anticipation in facioscapulohumeral muscular dystrophy type 1
    Zheng, Fuze
    Qiu, Liangliang
    Chen, Long
    Zheng, Ying
    He, Qifang
    Lin, Xiaodan
    Lin, Minting
    Lin, Yi
    Fu, Ying
    Wang, Ning
    Wang, Zhiqiang
    BRAIN, 2023, 146 (12) : E107 - E110
  • [46] Muscle imaging in facioscapulohumeral muscular dystrophy research: A scoping review and expert recommendations
    Vincenten, Sanne C. C.
    Teeselink, Sjan
    Mul, Karlien
    Heskamp, Linda
    Kan, Hermien E.
    Heerschap, Arend
    Cameron, Donnie
    Tasca, Giorgio
    Leung, Doris G.
    Voermans, Nicol C.
    van Engelen, Baziel G. M.
    van Alfen, Nens
    NEUROMUSCULAR DISORDERS, 2025, 47
  • [47] Quantitative muscle MRI and ultrasound for facioscapulohumeral muscular dystrophy: complementary imaging biomarkers
    Mul, Karlien
    Horlings, Corinne G. C.
    Vincenten, Sanne C. C.
    Voermans, Nicol C.
    van Engelen, Baziel G. M.
    van Alfen, Nens
    JOURNAL OF NEUROLOGY, 2018, 265 (11) : 2646 - 2655
  • [48] Delayed enhancement cardiac magnetic resonance imaging in a patient with Duchenne muscular dystrophy
    Guillaume, Melissa D.
    Phoon, Colin K. L.
    Chun, Anne J. L.
    Srichai, Monvadi B.
    TEXAS HEART INSTITUTE JOURNAL, 2008, 35 (03) : 367 - 368
  • [49] Muscle magnetic resonance imaging in patients with congenital muscular dystrophy and Ullrich phenotype
    Mercuri, E
    Cini, C
    Pichiecchio, A
    Allsop, J
    Counsell, S
    Zolkipli, Z
    Messina, S
    Kinali, M
    Brown, SC
    Jimenez, C
    Brockington, M
    Yuva, Y
    Sewry, CA
    Muntoni, F
    NEUROMUSCULAR DISORDERS, 2003, 13 (7-8) : 554 - 558
  • [50] Cardiovascular magnetic resonance imaging evaluation of two families with Becker muscular dystrophy
    Mavrogeni, Sophie
    Papavasiliou, Antigoni
    Skouteli, Eleni
    Magoutas, Anastasios
    Dangas, George
    NEUROMUSCULAR DISORDERS, 2010, 20 (11) : 717 - 719